Patrick G Enright insider trades

Open-market stock purchases and sales by Patrick G Enright, Director at Jazz Pharmaceuticals plc, from SEC Form 4 filings since Apr 21, 2010.

Track record: 58% of 12 scored buys are up 5% or more since purchase, averaging +32%.

Recent trades

DateStockTradeValue
Aug 31, 2026JAZZ Jazz Pharmaceuticals plcSold (not open market)$3.4K
Aug 31, 2026JAZZ Jazz Pharmaceuticals plcSold (not open market)$408K
Aug 5, 2026JAZZ Jazz Pharmaceuticals plcBought (not open market)—
Jun 15, 2026ZBIO Zenas BioPharma, IncBought (not open market)—
Jun 10, 2026BIOA BioAge Labs, IncBought (not open market)—
May 21, 2026VERA Vera Therapeutics, IncBought (not open market)—
Feb 5, 2026MANE Veradermics, IncBought (not open market)—
Feb 5, 2026MANE Veradermics, IncBought (not open market)—
Feb 5, 2026MANE Veradermics, IncBought$3.3M
Feb 5, 2026MANE Veradermics, IncBought$15M
Feb 3, 2026MANE Veradermics, IncBought (not open market)—
Dec 11, 2025VERA Vera Therapeutics, IncBought$250K
Oct 9, 2025ZBIO Zenas BioPharma, IncBought$2M
Oct 9, 2025ZBIO Zenas BioPharma, IncBought$250K

Companies traded

  • JAZZ Jazz Pharmaceuticals plc: 2 buys, 211 sales, last Aug 31, 2026
  • ZBIO Zenas BioPharma, Inc: 3 buys, last Jun 15, 2026
  • BIOA BioAge Labs, Inc: 1 buy, last Jun 10, 2026
  • VERA Vera Therapeutics, Inc: 8 buys, last May 21, 2026
  • MANE Veradermics, Inc: 2 buys, last Feb 5, 2026
  • APTX Aptinyx Inc: 3 buys, last May 26, 2022
  • AIMT Aimmune Therapeutics, Inc: 7 buys, 1 sale, last Oct 13, 2020
  • CORT Corcept Therapeutics Inc: 3 buys, 46 sales, last Mar 16, 2017
  • ESPR Esperion Therapeutics, Inc: 2 buys, 24 sales, last May 14, 2015

Get free alerts when Patrick G Enright files a new trade →